Works in any phone browserNo appNo installFree to start
Australia

Best Mole Check Apps in Australia (2026): An Honest Comparison

Australia has the world's highest skin cancer rates and the largest at-home AI screening market. Here's how the leading apps compare on accuracy, regulation, pricing and Fitzpatrick coverage.

April 2026CIBy Dr. Celina Kazumi IwasaEvidence-based
Share

Try the free option — built for monthly self-checks

Our AI analyzes skin concerns using clinical criteria in seconds.

TL;DR: Key Takeaways

  • Mole check apps are regulated as Software as a Medical Device (SaMD) under the TGA
  • ScanSkinAI: free first scan, UKCA Class I, ISO 27001/13485, Fitzpatrick I–VI validated
  • SkinVision: paid subscription (~AU$60+/year), CE-marked, established research base
  • MoleMap: clinical in-person total body photography service — not a consumer app
  • First Derm: pay-per-consult dermatologist review service

Why At-Home Screening Matters in Australia

Australia has the world's highest skin cancer rates — roughly two in three Australians will develop skin cancer by age 70 (full context in our Australian skin cancer overview). The RACGP recommends risk-based clinical screening (annually for moderate-risk, more frequently for high-risk) — see our Medicare skin check guide — which means most Australians spend 9–12 months between professional checks. AI mole-checking apps fill that gap with free or low-cost screening you can do at home in under a minute.

The Comparison: 4 Mole Check Tools for Australians in 2026

1. ScanSkinAI (UK-built, globally available)

UKCA Class I certified, ISO 27001 and ISO 13485 compliant. Uses a DINOv2-based vision model validated across Fitzpatrick I–VI. Free first scan with no card required. Provides triage advice, monthly comparison via stored baseline images, and clinical-grade PDF reports for sharing with your GP or skin cancer clinic.

  • Pricing: Free first scan; ~AU$24/3 months unlimited
  • Best for: Australians wanting free entry-point screening with regulatory certification
  • Limitations: Newer brand; no in-person clinical service

2. SkinVision (Netherlands)

One of the longest-established mole apps. CE Class IIa marked. Subscription-only — typically AU$60–80/year. Strong reputation and research base. Available on Australian app stores.

  • Pricing: ~AU$60–80/year, no free tier
  • Best for: Users wanting an established paid subscription product
  • Limitations: No free tier; generic global content rather than Australia-specific

3. MoleMap (in-clinic service, NZ origin, AU presence)

Not a consumer app — MoleMap is a clinical service offering total body photography and dermatologist review at physical clinics across Australia and NZ. Costs AU$300–$450 per full session. Uses high-resolution dermatoscopy and an internal AI assist. Best paired with home AI screening between visits.

  • Pricing: AU$300–$450 per session
  • Best for: High-risk patients wanting comprehensive baseline imaging
  • Limitations: In-person only; not a daily/monthly tool

4. First Derm (Sweden)

Pay-per-consult dermatologist review service. Upload photos, get a written reply within hours. AU$40–$60 per case. Useful for one-off second opinions; not designed for ongoing monitoring.

  • Pricing: AU$40–$60 per consultation
  • Best for: One-off second opinion from a real dermatologist
  • Limitations: Not a screening tool; no monitoring or photo comparison

Try the free Fitzpatrick-validated option

ScanSkinAI gives Australians a free, certified, monthly screening tool — perfect between annual GP or skin cancer clinic checks.

Try Free Mole Checker

What to Check Before Trusting Any App

  • Regulatory certification: ARTG listing (TGA), or equivalent UKCA/CE marking
  • Validation across Fitzpatrick skin types — including I, V and VI, not just III/IV
  • Clear data security commitments (ISO 27001 ideally)
  • Triage output that points you toward a healthcare professional, not a self-diagnosis
  • Photo storage that's secure and Australian Privacy Act compliant

How AI Apps Fit the Australian Pathway

The RACGP's risk-based approach assumes patients self-monitor between clinical checks. AI apps make that monitoring objective and persistent rather than memory-based. The realistic 2026 stack for an average-risk Australian: monthly AI self-check + annual GP or skin cancer clinic visit + UV-aware daily protection. See our Australian skin check guide for the full pathway and our UV index Australia guide for the daily protection layer. Wondering whether AI is accurate enough? Our AI vs dermatologist comparison covers the evidence.

To get the most out of any app, pair it with our monthly self-exam routine and learn the visual signs in our melanoma vs benign mole guide.

Why one check is rarely enough

A single scan tells you about one spot, on one day. But skin changes are about patterns over time — a new mole appearing, a slow shift in shape, size or colour, or a patch that simply isn't healing. Monitoring the same spots side-by-side, week after week, surfaces the subtle changes a one-off check will always miss — and gives you a clear record to show a clinician if something needs a closer look.

(ScanSkinAI is a screening and monitoring tool, not a diagnosis. Always see a clinician for anything that is changing, bleeding, or worrying you.)

Start 3-month monitoring

Unlimited scans · Track changes side-by-side · Cancel anytime

Related reading: How to Get a Skin Check in Australia · UV Index Australia Explained · AI Mole Checker vs Dermatologist · Skin monitoring hub

Frequently Asked Questions

Sources

  1. Moles: OverviewAmerican Academy of Dermatology (2024)
  2. Skin TagsAmerican Academy of Dermatology (2024)
  3. What to Look For: ABCDEs of MelanomaAmerican Academy of Dermatology (2024)
  4. Skin Cancer Warning SignsSkin Cancer Foundation (2024)

Dr. Celina Kazumi Iwasa

Verified

GMC-Registered · UK Hospital + Private Practice · Skin Cancer Screening Specialist

Dr. Iwasa is a GMC-registered dermatologist working across UK hospital and private practice settings. She specialises in skin cancer screening, mole assessment and dermoscopy, with a focus on UK and European patients across Fitzpatrick I–IV skin types.

United Kingdom · EuropeSkin cancer, mole checks, fair skin care
Meet our full clinical team

Medical Disclaimer: This article is for educational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions about a skin condition. If you think you may have a medical emergency, call your doctor or emergency services immediately.